Sexual Dysfunction Reduction in Female Patients with Chronic Kidney Disease Undergoing Continuous Ambulatory Peritoneal Dialysis
Background: chronic kidney disease (CKD) is a major worldwide health problem. One key treatment for end-stage CKD patients is dialysis therapy such as Continuous Ambulatory Peritoneal Dialysis (CAPD). This study aimed to find out the differences in the incidence of sexual dysfunction in women with CKD by CAPD. Methods: this study was a multicenter observational analytic study design in female samples before CAPD and after CAPD. It was conducted between November 2018 - January 2019 with 26 female respondents. They were assessed using the Female Sexual Function Index (FSFI) questionnaire at pre-CAPD and post-CAPD. Results: the results of the FSFI score before CAPD were 32.77 (SD 19.72) and after CAPD was 48.88 (SD 20.29). Analysis of differences in FSFI scores before and after CAPD demonstrates that there was a significant difference (p = 0.003). Conclusion: women with CKD who underwent CAPD, had an increase in FSFI scores compared to before CAPD. Thus, the use of CAPD can be seen to reduce sexual dysfunction and therefore improve the quality of life of women with CKD.
Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15:3-9.
Hansson JH, Watnick S. Core curriculum in nephrology update on peritoneal dialysis: Core curriculum 2016. Am J Kidney Dis. 2016;67:151-64.
Indonesian Renal Registry. 10th Report of Indonesian Renal Registry. 2017.
Rehman KU, Asif Mahmood M, Sheikh SS, Sultan T, Khan MA. The female sexual function index (FSFI): Translation, validation, and cross-cultural adaptation of an urdu version “FSFI-U”. Sex Med. 2015;3:244-50.
Strippoli GF, Vecchio M, Palmer S, et al. Collaborative depression and sexual Dysfunction (CDS) in Hemodialysis Working Group. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012;7:974-81.
Kim JH, Doo SW, Yang WJ, et al. Association between the hemodialysis adequacy and sexual dysfunction in chronic renal failure: a preliminary study. BMC Urology. 2014;14:4.
Santos PR, Capote JR Jr, Cavalcanti JU, et al. Quality of life among women with sexual dysfunction undergoing hemodialysis: a cross-sectional observational study. Health Qual Life Outcomes. 2012;10:103.
Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208.
Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits and access issues. Adv Chronic Kidney Dis. 2011;18:428-32.
Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:179-84.
Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The physiology of female sexual function and the pathophysiology of female sexual dysfunction (Committee 13A). J Sex Med. 2016;13:733-59.
Saraswati MR, Funistera SS. Disfungsi seksual pada wanita penderita diabetes melitus tipe 2. J Peny Dalam. 2011;12:92-7.
Esposito K, Ciotola M, Maiorino MI, et al. Hyperlipidemia and sexual function in premenopausal women. J Sex Med. 2009;6:1696-1703.
Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14:119-25.
Asdifard F, Mohamadi SZ, Heidari TBB. Sexual function of women with Chronic Renal Failure Undergoing Hemodialysis and factors related to it. Iran J Crit Care Nurs. 2013;5:204-13.
François K, Bargman JM. Evaluating the benefits of home-based peritoneal dialysis. Int J Nephrol Renovasc Dis. 2014;7:447-55.
Saglimbene V, Natale P, Palmer S, et al. The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study. PLoS ONE 2017; 12(6); 1-12.
Jung HY, Jeon Y, Park Y, et al. Better quality of life of peritoneal dialysis compared to hemodialysis over a two-year period after dialysis initiation. Scientific Reports. 2019-9:10266;1-1.
Fang Z, Jinit M, Attia A, et al. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity. 2016-8;396-403.
- There are currently no refbacks.